文献速递新生儿儿童感染儿童消化与营养

新生儿重症监护病房常规接种轮状病毒疫苗的传播风险

Risk of Transmission of Vaccine-Strain Rotavirus in a Neonatal Intensive Care Unit That Routinely Vaccinates.
PubMed 文献 · Pediatrics · 2025-01-01

该前瞻性队列研究在100张床位的NICU开展1年,共纳入1238名婴儿,每周采集粪便用实时定量逆转录聚合酶链反应检测RV5株。未接种婴儿中仅5例(<1%)检出疫苗株,传播率估计为2.2/1000患者日风险(95%CI: 0.7-5.2),且无胃肠炎症状。结论认为疫苗株传播不频繁且无临床后果,NICU内接种RV5的获益超过传播风险。

要点

  • 未接种婴儿中RV5疫苗株传播率低,估计为2.2/1000患者日风险(95%CI: 0.7-5.2)。
  • 传播病例在粪便检出RV5株后7天内均未出现胃肠炎症状。
  • 若仅出院时接种,55%已启动系列的婴儿将超龄无法开始接种。

核心结论

  • RV5疫苗株在NICU内传播不频繁且无临床后果,常规接种的获益似乎超过传播风险。

研究设计与样本

  • 前瞻性队列研究,纳入100张床位NICU一年内收治的所有1238名婴儿。
  • 每周采集粪便,用实时定量逆转录聚合酶链反应检测RV5株。
  • 未接种婴儿的传播发病率按每份粪便对应1个患者日风险计算。

主要发现

  • 1238名婴儿中560名(45%)为早产儿,322名(26%)有胃肠道病理。
  • 观察期间共接种226剂RV5,检测3448份粪便样本,其中2252份来自686名未接种患者。
  • 681名(99.3%)未接种患者从未检出RV5株,5名(<1%)检出阳性。
  • 传播率估计为5/2252份粪便或2.2/1000患者日风险(95%CI: 0.7-5.2)。
  • 传播病例在粪便采集后7天内未发现胃肠炎症状。

关键数值与推荐

  • 未接种婴儿中RV5株传播率为2.2/1000患者日风险(95%CI: 0.7-5.2)。
  • 126名在出院前启动RV5系列的婴儿中,55%若仅允许出院时接种将超龄无法开始。

临床怎么用

  • NICU常规接种RV5时疫苗株传播风险低且无临床后果,可考虑允许接种以提供保护。
  • 仅出院时接种可能导致大量婴儿超龄无法启动系列,应关注接种时机。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Many neonatal intensive care units (NICUs) do not give rotavirus vaccines to inpatients due to a theoretical risk of horizontal transmission of vaccine strains. We aimed to determine incidence and clinical significance of vaccine-strain transmission to unvaccinated infants in a NICU that routinely administers pentavalent rotavirus vaccine (RV5). METHODS: This prospective cohort study included all patients admitted to a 100-bed NICU for 1 year. Stool specimens were collected weekly; real-time quantitative reverse-transcription polymerase chain reaction was used to detect any RV5 strain. Incidence of transmission to unvaccinated infants was calculated assuming each unvaccinated patient's stool contributed 1 patient-day at risk for transmission. Investigations and geospatial analyses were conducted for suspected transmission events. RESULTS: Of 1238 infants admitted, 560 (45%) were premature and 322 (26%) had gastrointestinal pathology. During observation, 226 RV5 doses were administered. Overall, 3448 stool samples were tested, including 2252 from 686 unvaccinated patients. Most (681, 99.3%) unvaccinated patients never tested positive for RV5 strain. Five (<1%) tested RV5 strain positive. The estimated rate of transmission to unvaccinated infants was 5/2252 stools or 2.2/1000 patient-days at risk (95% CI: 0.7-5.2). No gastroenteritis symptoms were identified in transmission cases within 7 days of collection of RV5-positive stool. Of 126 patients for whom the RV5 series was initiated before the discharge date, 55% would have become age-ineligible to start the series if vaccination was allowed only at discharge. CONCLUSIONS: Transmission of RV5 strain was infrequent and without clinical consequences. Benefits of allowing vaccine-induced protection against rotavirus disease in infants through in-NICU RV5 vaccination appear to have outweighed risks from vaccine-strain transmission.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Zalot MA, Cortese MM, O'Callaghan KP, et al. Risk of Transmission of Vaccine-Strain Rotavirus in a Neonatal Intensive Care Unit That Routinely Vaccinates. Pediatrics. 2025. PMID: 39652114. doi:10.1542/peds.2024-067621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。